NCT00165217View on ClinicalTrials.gov

Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Colorectal Adenocarcinoma
Interventions
DRUG

Capecitabine

DRUG

Thalidomide

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00165217 - Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | Biotech Hunter | Biotech Hunter